Market Closed -
Bombay S.E.
06:12:52 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
179.6
INR
|
-1.83%
|
|
+0.14%
|
+6.12%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,259
|
1,391
|
713.4
|
1,631
|
2,205
|
1,163
|
Enterprise Value (EV)
1 |
1,445
|
1,568
|
885.2
|
1,862
|
2,489
|
1,440
|
P/E ratio
|
48.5
x
|
39.4
x
|
15.4
x
|
23.8
x
|
29.9
x
|
61.8
x
|
Yield
|
0.49%
|
0.44%
|
0.87%
|
0.53%
|
0.42%
|
0.99%
|
Capitalization / Revenue
|
1.59
x
|
1.55
x
|
0.77
x
|
1.37
x
|
1.66
x
|
0.87
x
|
EV / Revenue
|
1.82
x
|
1.74
x
|
0.96
x
|
1.57
x
|
1.87
x
|
1.07
x
|
EV / EBITDA
|
39.6
x
|
23.3
x
|
10.1
x
|
11.3
x
|
17.2
x
|
12.7
x
|
EV / FCF
|
-11
x
|
-149
x
|
-56
x
|
-29.2
x
|
-18.5
x
|
29.9
x
|
FCF Yield
|
-9.11%
|
-0.67%
|
-1.79%
|
-3.43%
|
-5.4%
|
3.34%
|
Price to Book
|
4.97
x
|
4.94
x
|
2.23
x
|
4.03
x
|
4.21
x
|
2.19
x
|
Nbr of stocks (in thousands)
|
9,656
|
9,656
|
9,656
|
11,937
|
12,812
|
12,812
|
Reference price
2 |
130.4
|
144.1
|
73.88
|
136.6
|
172.1
|
90.75
|
Announcement Date
|
8/14/18
|
9/7/19
|
9/8/20
|
8/25/21
|
8/23/22
|
9/7/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
792
|
900.1
|
922.5
|
1,187
|
1,332
|
1,339
|
EBITDA
1 |
36.5
|
67.21
|
87.32
|
164.5
|
144.4
|
113.7
|
EBIT
1 |
29.47
|
60.85
|
67.73
|
107
|
94.82
|
59.28
|
Operating Margin
|
3.72%
|
6.76%
|
7.34%
|
9.02%
|
7.12%
|
4.43%
|
Earnings before Tax (EBT)
1 |
33.92
|
50.29
|
68.76
|
95.58
|
97.41
|
27.28
|
Net income
1 |
22.52
|
35.3
|
46.23
|
68.52
|
69.68
|
18.72
|
Net margin
|
2.84%
|
3.92%
|
5.01%
|
5.77%
|
5.23%
|
1.4%
|
EPS
2 |
2.689
|
3.656
|
4.788
|
5.741
|
5.751
|
1.469
|
Free Cash Flow
1 |
-131.6
|
-10.53
|
-15.81
|
-63.86
|
-134.5
|
48.1
|
FCF margin
|
-16.62%
|
-1.17%
|
-1.71%
|
-5.38%
|
-10.09%
|
3.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
42.32%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
256.96%
|
Dividend per Share
2 |
0.6400
|
0.6400
|
0.6400
|
0.7200
|
0.7200
|
0.9000
|
Announcement Date
|
8/14/18
|
9/7/19
|
9/8/20
|
8/25/21
|
8/23/22
|
9/7/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
187
|
177
|
172
|
231
|
284
|
277
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.113
x
|
2.633
x
|
1.968
x
|
1.403
x
|
1.968
x
|
2.436
x
|
Free Cash Flow
1 |
-132
|
-10.5
|
-15.8
|
-63.9
|
-134
|
48.1
|
ROE (net income / shareholders' equity)
|
10.1%
|
13.3%
|
15.5%
|
18.9%
|
15.1%
|
3.56%
|
ROA (Net income/ Total Assets)
|
3.16%
|
5.29%
|
5.03%
|
6.6%
|
5.07%
|
2.96%
|
Assets
1 |
712.4
|
667.4
|
919.7
|
1,039
|
1,374
|
633.3
|
Book Value Per Share
2 |
26.30
|
29.10
|
33.10
|
33.90
|
40.80
|
41.40
|
Cash Flow per Share
2 |
0.1600
|
1.700
|
4.380
|
4.190
|
1.420
|
3.420
|
Capex
1 |
47.5
|
117
|
113
|
14.9
|
135
|
31.1
|
Capex / Sales
|
6%
|
13.02%
|
12.2%
|
1.25%
|
10.13%
|
2.32%
|
Announcement Date
|
8/14/18
|
9/7/19
|
9/8/20
|
8/25/21
|
8/23/22
|
9/7/23
|
|
1st Jan change
|
Capi.
|
---|
| +6.12% | 28.02M | | +14.70% | 64.97B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|